OFI INVEST ASSET MANAGEMENT

Position in GILD — Gilead Sciences, Inc.

CIK 1977602 ISSY LES MOULINEAUX, I0

Position in GILD

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$38,883,282

-$5,761,667 QoQ

Shares Held

307,767

-3.9% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#243

of 2,266 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OFI INVEST ASSET MANAGEMENT holds $330,320,760 across 8 Drug Manufacturers - General names. GILD ranks #4 (11.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	101,109	$121,273,177
2	MRK	Merck & Co., Inc.	569,512	$73,182,292
3	ABBV	AbbVie Inc.	274,288	$69,021,832
4	GILD	Gilead Sciences, Inc. This page	307,767	$38,883,282
5	PFE	Pfizer Inc	751,408	$18,093,904
6	JNJ	Johnson & Johnson	18,967	$4,817,048
7	AMGN	Amgen Inc	12,932	$4,682,935
8	BMY	Bristol Myers Squibb Co	6,357	$366,290

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$38,883,282	307,767	-3.9%	Shares	Sole	2026-07-17
2026-03-31	$44,644,949	320,334	-62.3%	Shares	Sole	2026-05-05
2025-12-31	$104,240,258	849,277	+124.4%	Shares	Sole	2026-01-22
2025-09-30	$42,010,503	378,473	+92.9%	Shares	Sole	2025-10-14
2025-06-30	$21,756,020	196,230	-30.7%	Shares	Sole	2025-07-25
2025-03-31	$31,715,416	283,047	+0.5%	Shares	Sole	2025-05-09
2024-12-31	$26,013,424	281,622	+60204.5%	Shares	Sole	2025-02-07
2024-06-30	$32,040	467	+27.2%	Shares	Sole	2024-07-19
2024-03-31	$26,882	367	+3.1%	Shares	Sole	2024-04-29
2023-12-31	$28,839	356	-1.4%	Shares	Sole	2024-02-14
2023-09-30	$27,053	361	-99.8%	Shares	Sole	2023-11-02
2023-03-31	$2,811	233,229	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.